Ligand Pharmaceuticals Inc LGND:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 3:46 PM EDT
85.27quote price arrow up+1.20 (+1.43%)
Volume
92,693
52 week range
49.24 - 94.57
Loading...
  • Open84.56
  • Day High85.76
  • Day Low84.54
  • Prev Close84.07
  • 52 Week High94.57
  • 52 Week High Date02/27/24
  • 52 Week Low49.24
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.532B
  • Shares Out17.96M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change19.71

KEY STATS

  • Open84.56
  • Day High85.76
  • Day Low84.54
  • Prev Close84.07
  • 52 Week High94.57
  • 52 Week High Date02/27/24
  • 52 Week Low49.24
  • 52 Week Low Date10/27/23
  • Market Cap1.532B
  • Shares Out17.96M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change19.71

RATIOS/PROFITABILITY

  • EPS (TTM)5.23
  • P/E (TTM)16.29
  • Fwd P/E (NTM)19.90
  • EBITDA (TTM)34.391M
  • ROE (TTM)13.26%
  • Revenue (TTM)118.313M
  • Gross Margin (TTM)91.82%
  • Net Margin (TTM)81.43%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ligand Pharmaceuticals Inc

 

Profile

MORE
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved...
John Kozarich Ph.D.
Non-Executive Independent Chairman of the Board
Todd Davis
Chief Executive Officer, Director
Matthew Korenberg
President, Chief Operating Officer
Octavio Espinoza
Chief Financial Officer
Address
555 Heritage Drive, Suite 200
Jupiter, FL
33458
United States

Top Peers

SYMBOLLASTCHG%CHG
RCUS
Arcus Biosciences Inc
17.10-0.11-0.64%
XNCR
Xencor Inc
20.38-0.96-4.50%
VIR
Vir Biotechnology Inc
10.11+0.34+3.43%
ARDX
Ardelyx Inc
7.76-0.25-3.18%
TARS
Tarsus Pharmaceuticals Inc
38.01-0.36-0.94%